Effects of orally administered galacto-oligosaccharides on immunological parameters in foals: a pilot study.

BMC Vet Res 2014 Nov 19;10:278. Epub 2014 Nov 19.

Background: In the first phase of life, in which the immune system is primed and the bacterial colonization of epithelial surfaces takes place, foals are highly susceptible to bacterial infections. Next to strategies to optimize maternally acquired immunity in individual foals, current research explores other options to modulate immune responses in foals. During the past decades, oligosaccharide supplements were developed to mimic beneficial properties of the oligosaccharides, which are present in colostrum and milk. In human infants and laboratory animal species, dietary supplementation with galacto-oligosaccharides (GOS) has been shown to result in prebiotic and immunomodulating effects, with long-term beneficial consequences for both defensive and allergic immune responses. As yet, no studies are published concerning the in vivo effects of GOS in horses. The current study was designed as a pilot study to investigate the effects of an orally applied, commercially available GOS product in a group of pony foals. The treatment and the control group consisted of six and four foals, respectively. Foals were treated during the first four weeks of life and subsequently followed up for another ten weeks.

Results: In peripheral blood mononuclear cells (PBMCs) derived from GOS-treated foals at day 28, a standardized lipopolysaccharide challenge resulted in significantly lower relative mRNA expression levels of the pro-inflammatory cytokines interferon-γ and interleukin-6 compared with PBMCs of control foals. In the 98-day period of investigation, no significant effects of the GOS supplement were observed on clinical and blood parameters for immunity and general health in these foals.

Conclusions: Based on these first results, we can conclude that this dose regimen of GOS was well accepted by the foals and did not result in any detectable undesirable side effects. More clinical trials are required to confirm the attenuating effects of GOS treatment on equine pro-inflammatory immune responses and to implement this into practice.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12917-014-0278-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241218PMC
November 2014
5 Reads

Publication Analysis

Top Keywords

effects gos
12
immune responses
12
foals
10
pilot study
8
effects orally
8
effects
7
gos
6
gos horses
4
horses current
4
blood parameters
4
vivo effects
4
studies published
4
published concerning
4
parameters immunity
4
concerning vivo
4
study designed
4
observed clinical
4
orally applied
4
supplement observed
4
applied commercially
4

References

(Supplied by CrossRef)

R Martin et al.
Benef Microbes 2010

LM Davis et al.
Int J Food Microbiol 2010

S Fanaro et al.
J Pediatr Gastroenterol Nutr 2009

XM Ben et al.
World J Gastroenterol 2008

V Sangwan et al.
J Food Sci 2011

A Gopalakrishnan et al.
J Nutr 2012

AP Vos et al.
Pediatr Allergy Immunol 2007

MA Schijf et al.
J Virol 2012

S Arslanoglu et al.
J Nutr 2007

P Chatchatee et al.
J Pediatr Gastroenterol Nutr 2014

N Niele et al.
Eur J Pediatr 2013

Similar Publications